BHWM
AGIO icon

Bay Harbor Wealth Management’s Agios Pharmaceuticals AGIO Stock Holding History

Bay Harbor Wealth Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$74 Hold
2
– – ﹤0.01% 1245
2026
Q1 		$67 Sell
2
-2
-50% -$57 ﹤0.01% 1239
2025
Q4 		$108 Buy
4
+1
+33% +$35 ﹤0.01% 1199
2025
Q3 		$120 Buy
3
+1
+50% +$38 ﹤0.01% 1142
2025
Q2 		$66 Buy
2
+1
+100% +$30 ﹤0.01% 1161
2025
Q1 		$29 Buy
+1
New +$33 ﹤0.01% 1091

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Bay Harbor Wealth Management's AGIO Position: Q2 2026 in Review

Bay Harbor Wealth Management held its Agios Pharmaceuticals (AGIO) position steady in Q2 2026 at 2 shares worth $74. The position accounts for ﹤0.01% of the portfolio, ranked #1245.

Bay Harbor Wealth Management first reported a position in AGIO in Q1 2025 and has held it in 6 quarters since. The position peaked at $120 in Q3 2025. 239 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Bay Harbor Wealth Management held 2 shares of Agios Pharmaceuticals worth $74 as of Q2 2026.
  • Bay Harbor Wealth Management left its Agios Pharmaceuticals share count unchanged in Q2 2026.
  • Agios Pharmaceuticals made up ﹤0.01% of Bay Harbor Wealth Management's portfolio in Q2 2026, its #1245 holding.
  • Bay Harbor Wealth Management first reported a position in Agios Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Bay Harbor Wealth Management's Agios Pharmaceuticals position peaked at $120 in Q3 2025.
  • 239 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Bay Harbor Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.